Navigation Links
Low-Dose Oral Contraceptives May Increase Risk of Pelvic Pain During Sexual Climax
Date:5/3/2013

SAN DIEGO, May 3, 2013 /PRNewswire-USNewswire/ -- Low-dose (low estrogen) oral contraceptives (OCPs) may increase a woman's risk for chronic pelvic pain symptoms (CPPS) and even pain during sexual climax, according to a new study. This study will be presented to reporters at the 108th Annual Scientific Meeting of the American Urological Association (AUA) during a press conference at the San Diego Convention Center, San Diego, CA on May 7 at 11:00 a.m. PDT.

Oral contraceptives have been available in the United States for more than half a century and while considered innocuous today (because of lower doses of estrogen) than even 25 years ago, their effects on conditions such as CPPS are not yet fully understood. Therefore researchers from New York University and Waitemata District Health Board in Auckland, New Zealand conducted a study to compare CPPS between young women who are current OCP users and non-users.

Researchers used data collected from an anonymous, Internet-based survey of women 18-39 years of age within large university populations. The researchers did not include women who were pregnant or had a history of endometriosis or pelvic pain, and gathered demographic data as well as information on the type of OCP, duration of use, and indication for usage. Once data was collected, respondents were sorted into the following groups:

  • Not using an OCP
  • Taking a low-dose of estrogen
  • Taking a normal dose (>20mcg) of estrogen

Additionally, respondents were classified as having CPPS if their total index pain score was greater than or equal to four. The researchers then compared the responses between the groups.

Of the 932 respondents who were eligible for the study, 605 were categorized as non-OCP users and 327 were categorized as OCP users, with 169 using low-dose and 171 using normal dose OCPs. The researchers found significant differences in the incidence of individual pelvic pain symptoms between OCP users and non−users and further differences with low−dose use. Specifically, results showed:

  • Low−dose OCP users were more likely to report pelvic pain symptoms and more likely to have CPPS than non−users (27.1 percent vs. 17.5 percent, p=0.045).
  • Low-dose OCP users had almost twice the incidence of pain or discomfort during or after sexual climax compared to controls, and there was no difference between normal dose OCP users and controls.
  • Normal dose OCP users were less likely to have pelvic pain symptoms than non OCP users.
  • Forty-four percent of respondents reported onset of pain after beginning OCP use and were more likely to fulfill CPPS criteria than those who had symptoms prior to OCP use (62 percent vs. 30.3 percent, p<0.001).

"This study reveals valuable insights into the relationship between oral contraceptives, pelvic pain and how effects may differ depending on hormone dosage," said Dr. Kristene Whitmore , chair of urology and female pelvic medicine and reconstructive surgery and professor of urology and OBGYN at Drexel University College of Medicine. "It also has been recently reported that patients have an increased incidence of vulvodynia when taking low dose OCPs, therefore additional research is needed to determine if the chronic pelvic pain noted in this study is related to vulvar pain or the hormone dosage."

About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has more than 19,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.


'/>"/>
SOURCE American Urological Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Noven Announces FDA Advisory Committee Vote on Investigational Low-Dose Mesylate Salt of Paroxetine (LDMP) for Vasomotor Symptoms Associated with Menopause
2. Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen
3. Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62
4. Actavis First Quarter 2013 Net Revenue Increases 24% to $1.9 Billion
5. HeartWare International Reports $49.2 Million In First Quarter 2013 Revenue; 87% Increase From First Quarter Of 2012
6. Chindex-Fosun Pharma Joint Venture, Chindex Medical, To Participate in Acquisition of Alma Lasers; Fosun Pharma Increases Investment in Chindex Medical
7. Amgens First Quarter 2013 Revenues Increased 5 Percent To $4.2 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $1.96
8. Covance Expands Singapore Central Laboratory by 50 Percent to Meet Clients Increased Asia Pacific Focus
9. Hemodialysis Patient Share for Sanofis Ferrlecit Increased Significantly in the First Quarter of 2013 Compared to the Previous Quarter
10. Wright, Biomet, Stryker Hip Recall Settlement Funding News: Legal-Bay To Increase Funding Amounts Up to $50K
11. Western European Endoscopic Devices Market to Benefit from Increase in Minimally Invasive Surgeries, Says Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... Aug. 15, 2017   Mostyn Law and Gulf Coast ... Houston, Texas . The Mostyn Law family has ... years. That is why Mostyn Law is partnering with ... to show its appreciation. Blood supplies are running low. ... short of hospital needs in August. That is why the blood ...
(Date:8/14/2017)... Israel , Aug. 15, 2017 /PRNewswire/ ... of adult stem cell technologies for neurodegenerative diseases, announced ... 2017. "We are ... Phase 3 trial to investigate NurOwn ® in ... Executive Officer of BrainStorm. "We have agreements with Mass. ...
(Date:8/7/2017)... 7, 2017 Insightin Health, provider of ... and engagement, announced the selection of Michael ... Development, effective as of February 2017. In this role, ... strategy for our clients. Wood brings with him ... and business analytics within the healthcare industry. Wood ...
Breaking Medicine Technology:
(Date:8/17/2017)... ... August 17, 2017 , ... Dr. Charles W. Grimsley’s new ... ($15.99, paperback, 9781498497626; $7.99, eBook, 9781498497633) focuses on the treatment of veterans diagnosed ... achieve forgiveness, through a progressive journey toward healing. This book will help readers ...
(Date:8/17/2017)... , ... August 17, 2017 , ... Advice Media, the industry leader in digital marketing ... in North America and has been included in the Inc. 5000 for the second time ... to be included in the Inc. 5000 rankings for the second year in a row. ...
(Date:8/16/2017)... ... August 16, 2017 , ... Summer days spent with family are priceless. ... put together suggestions for enjoying the season of sunshine. Add trying something new to ... family can join in on the fun. , Try Something New ...
(Date:8/16/2017)... ... August 16, 2017 , ... Ten outstanding teachers in the Greater ... Classroom and will win a visit by a Houston Texans player, two tickets to ... least five years old can visit texanschecking.com/stars to nominate their favorite teacher with an ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... In a ... its appearance with diet and exercise. In fact, cellulite can't always be eliminated by ... and more effective treatment available to select physicians nationwide. Dr. Kenneth Rothaus has recently ...
Breaking Medicine News(10 mins):